Matches in Nanopublications for { ?s ?p "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP420048.RAoeV53cGyfIzldaeYXb3-oM2DWWvWxB22nMwPLEu2SQE130_assertion description "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420048.RAoeV53cGyfIzldaeYXb3-oM2DWWvWxB22nMwPLEu2SQE130_provenance.
- NP420049.RAHPs5Ag7fGpMXQcRhpudT7dQt8yE5-aXqQGtYAex3HIE130_assertion description "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420049.RAHPs5Ag7fGpMXQcRhpudT7dQt8yE5-aXqQGtYAex3HIE130_provenance.
- NP420050.RAGm7oxV03L_nlcX-fxtKMzkxpHcYxvTVnFrE4Su2-nMU130_assertion description "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420050.RAGm7oxV03L_nlcX-fxtKMzkxpHcYxvTVnFrE4Su2-nMU130_provenance.
- NP420051.RAJuGpooG4vfOjCPAD2YKIFMUxqtRaSRSHtZKQBGB84oE130_assertion description "[Because the apolipoprotein epsilon4 (APOE-epsilon4) allele or depressive symptoms may increase the risk for development of Alzheimer disease (AD), the authors assessed APOE-epsilon4 status, baseline level of depressive symptoms, and subsequent cognitive decline in middle-aged and older persons without dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420051.RAJuGpooG4vfOjCPAD2YKIFMUxqtRaSRSHtZKQBGB84oE130_provenance.